DOI QR코드

DOI QR Code

A Comparison of ROCK Inhibitors on Human Bone Marrow-Derived Mesenchymal Stem Cell Differentiation into Neuron-Like Cells

  • Lee, Hyun-Sun (Cancer Research Institute and Department of Biomedical Sciences, The Catholic University of Korea, College of Medicine) ;
  • Kim, Kwang-Sei (Cancer Research Institute and Department of Biomedical Sciences, The Catholic University of Korea, College of Medicine) ;
  • O, Eun-Ju (Cancer Research Institute and Department of Biomedical Sciences, The Catholic University of Korea, College of Medicine) ;
  • Joe, Young-Ae (Cancer Research Institute and Department of Biomedical Sciences, The Catholic University of Korea, College of Medicine)
  • Received : 2010.05.25
  • Accepted : 2010.05.29
  • Published : 2010.10.31

Abstract

Bone marrow-derived mesenchymal stem cells (BM-MSC) are a multipotent cell population that can differentiate into neuron-like cells. Previously it has been reported that murine BM-MSC can differentiate into neuron-like cells by co-treatment with a Rho-associated kinase (ROCK) inhibitor -Y27632 and $CoCl_2$. In this study, we compared several ROCK inhibitors for the ability to induce human BM-MSCs to differentiate into neuron-like cells in the presence of $CoCl_2$. Y27632 with high specificity for ROCK at 1-30 ${\mu}M$ was best at inducing neuronal differentiation of MSCs. Compared to HA1077 and H1152, which also effectively induced morphological change into neuron-like cells, Y27632 showed less toxicity even at 100 ${\mu}M$, and resulted in longer multiple branching processes at a wide range of concentrations at 6 h and 72 h post-induction. H89, however, which has less specificity by inhibition of protein kinase A, S6 kinase 1 and MSK1 with similar or greater potency, was less effective at inducing neuronal differentiation of MSCs. Simvastatin, which can inhibit Rho, Ras, and Rac by blocking the synthesis of isoprenoid intermediates, showed little activity for inducing morphological changes of MSCs into neuron-like cells. Accordingly, the expression patterns for neuronal cell markers,including ${\beta}$-tubulin III, neuron-specific enolase, neurofilament, and microtubule-associated protein, were consistent with the pattern of the morphological changes. The data suggest that the ROCK inhibitors with higher specificity are more effective at inducing neuronal differentiation of MSCs.

Keywords

References

  1. Chen, J., Li, Y., Wang, L., Zhang, Z., Lu, D., Lu, M. and Chopp, M. (2001). Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32, 1005-1011. https://doi.org/10.1161/01.STR.32.4.1005
  2. Davies, S. P., Reddy, H., Caivano, M. and Cohen, P. (2000). Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95-105. https://doi.org/10.1042/0264-6021:3510095
  3. Dezawa, M., Ishikawa, H., Hoshino, M., Itokazu, Y. and Nabeshima, Y. (2005). Potential of bone marrow stromal cells in applications for neuro-degenerative, neuro-traumatic and muscle degenerative diseases. Curr. Neuropharmacol. 3, 257-266. https://doi.org/10.2174/157015905774322507
  4. Grove, J. E., Bruscia, E. and Krause, D. S. (2004). Plasticity of bone marrow-derived stem cells. Stem Cells 22, 487-500. https://doi.org/10.1634/stemcells.22-4-487
  5. Heng, B. C. (2009). Effect of Rho-associated kinase (ROCK) inhibitor Y-27632 on the post-thaw viability of cryopreserved human bone marrow-derived mesenchymal stem cells. Tissue Cell 41, 376-380. https://doi.org/10.1016/j.tice.2009.01.004
  6. Hofstetter, C. P., Schwarz, E. J., Hess, D., Widenfalk, J., El Manira, A., Prockop, D. J. and Olson, L. (2002). Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc. Natl. Acad. Sci. U S A 99, 2199-2204. https://doi.org/10.1073/pnas.042678299
  7. Kubo, T., Yamaguchi, A., Iwata, N. and Yamashita, T. (2008). The therapeutic effects of Rho-ROCK inhibitors on CNS disorders. Ther. Clin. Risk Manag. 4, 605-615. https://doi.org/10.2147/TCRM.S2907
  8. Li, Y., Chen, J. and Chopp, M. (2001). Adult bone marrow transplantation after stroke in adult rats. Cell Transplant. 10, 31-40.
  9. Liao, J. K., Seto, M. and Noma, K. (2007). Rho kinase (ROCK) inhibitors. J. Cardiovasc. Pharmacol. 50, 17-24. https://doi.org/10.1097/FJC.0b013e318070d1bd
  10. Luo, L. (2000). Rho GTPases in neuronal morphogenesis. Nat. Rev. Neurosci. 1, 173-180. https://doi.org/10.1038/35044547
  11. Mahmood, A., Lu, D., Wang, L., Li, Y., Lu, M. and Chopp, M. (2001). Treatment of traumatic brain injury in female rats with intravenous administration of bone marrow stromal cells. Neurosurgery 49, 1196-1203; discussion 1203-1194. https://doi.org/10.1097/00006123-200111000-00031
  12. Olson, M. F. (2008). Applications for ROCK kinase inhibition. Curr. Opin. Cell Biol. 20, 242-248. https://doi.org/10.1016/j.ceb.2008.01.002
  13. Pacary, E., Legros, H., Valable, S., Duchatelle, P., Lecocq, M., Petit, E., Nicole, O. and Bernaudin, M. (2006). Synergistic effects of CoCl(2) and ROCK inhibition on mesenchymal stem cell differentiation into neuron-like cells. J. Cell Sci. 119, 2667-2678. https://doi.org/10.1242/jcs.03004
  14. Pacary, E., Petit, E. and Bernaudin, M. (2008). Concomitant inhibition of prolyl hydroxylases and ROCK initiates differentiation of mesenchymal stem cells and PC12 towards the neuronal lineage. Biochem. Biophys. Res. Commun. 377, 400-406. https://doi.org/10.1016/j.bbrc.2008.09.145
  15. Pacary, E., Tixier, E., Coulet, F., Roussel, S., Petit, E. and Bernaudin, M. (2007). Crosstalk between HIF-1 and ROCK pathways in neuronal differentiation of mesenchymal stem cells, neurospheres and in PC12 neurite outgrowth. Mol. Cell Neurosci. 35, 409-423. https://doi.org/10.1016/j.mcn.2007.04.002
  16. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S. and Marshak, D. R. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147. https://doi.org/10.1126/science.284.5411.143
  17. Sanchez-Ramos, J., Song, S., Cardozo-Pelaez, F., Hazzi, C., Stedeford, T., Willing, A., Freeman, T. B., Saporta, S., Janssen, W., Patel, N., Cooper, D. R. and Sanberg, P. R. (2000). Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp. Neurol. 164, 247-256. https://doi.org/10.1006/exnr.2000.7389
  18. Sasaki, Y., Suzuki, M. and Hidaka, H. (2002). The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5- isoquinoline)sulfonyl]-homopiperazine as a probing molecule for Rho-kinase-involved pathway. Pharmacol. Ther. 93, 225-232. https://doi.org/10.1016/S0163-7258(02)00191-2
  19. Schmandke, A. and Strittmatter, S. M. (2007). ROCK and Rho: biochemistry and neuronal functions of Rho-associated protein kinases. Neuroscientist 13, 454-469. https://doi.org/10.1177/1073858407303611
  20. Shi, J. and Wei, L. (2007). Rho kinase in the regulation of cell death and survival. Arch. Immunol. Ther. Exp. (Warsz) 55, 61-75. https://doi.org/10.1007/s00005-007-0009-7
  21. Van Aelst, L. and Cline, H. T. (2004). Rho GTPases and activitydependent dendrite development. Curr. Opin. Neurobiol. 14, 297-304. https://doi.org/10.1016/j.conb.2004.05.012
  22. Woodbury, D., Schwarz, E. J., Prockop, D. J. and Black, I. B. (2000). Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res. 61, 364-370. https://doi.org/10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C

Cited by

  1. A ROCK Inhibitor Blocks the Inhibitory Effect of Chondroitin Sulfate Proteoglycan on Morphological Changes of Mesenchymal Stromal/Stem Cells into Neuron-Like Cells vol.21, pp.6, 2013, https://doi.org/10.4062/biomolther.2013.041
  2. Promotion of mouse embryonic stem cell differentiation by Rho kinase inhibitor Y-27632 vol.579, 2014, https://doi.org/10.1016/j.neulet.2014.07.011
  3. Rho kinase inhibitor Y-27632 promotes neuronal differentiation in mouse embryonic stem cells via phosphatidylinositol 3-kinase vol.615, 2016, https://doi.org/10.1016/j.neulet.2016.01.022
  4. A Novel Peptide Derived From Tissue-Type Plasminogen Activator Potently Inhibits Angiogenesis and Corneal Neovascularization vol.118, pp.5, 2017, https://doi.org/10.1002/jcb.25732
  5. Enhancement of Endothelial Progenitor Cell Numbers and Migration by H1152, a Rho Kinase Specific Inhibitor vol.76, pp.1, 2010, https://doi.org/10.1271/bbb.110468